Literature DB >> 26215181

The report of sequence analysis on familial Mediterranean fever gene (MEFV) in South-eastern Mediterranean region (Kahramanmaraş) of Turkey.

Metin Kilinc1, Eda Ganiyusufoglu2, Hatice Sager3, Ahmet Celik4, Seref Olgar5, Gozde Yildirim Cetin6, Mehmet Davutoglu7, Orcun Altunoren8.   

Abstract

Familial Mediterranean fever (FMF) is defined as an inherited and autosomal recessive disease. Many researches have been done about this subject, and we believe that it should be necessary to focus on phenotype-genotype correlation, especially novel mutation types. We aim to announce the results of FMF sequence analysis in Kahramanmaras/Turkey. The number of participants is 380 males and 451 females who clinically diagnosed as FMF subjects of different age groups. Genomic sequences of exons 2 and 10 and in some cases exon 3 of the MEFV gene were scanned for mutations by sequence analyzer. The most common mutation identified in 230 (57.07 %) patients is heterozygous. The frequencies of mutation types in heterozygous subjects are R202Q (39.13 %), E148Q (18.70 %), M680I (16.52 %), M694V (13.91 %), and V726A (4.78 %), respectively. The most striking point among the compound heterozygous subjects is R202Q/M694V mutation type found at the highest rate (32 subjects). Fever and peritonitis are the most frequent signs of homozygous M694V and combine heterozygous mutations. Interestingly, the rate of homozygous mutation types (M694V/M694V+ R202Q/R202Q) is 96.70 % among all compound homozygous mutation types. The most frequent rate of homozygous patients is M680I mutation types (68.42 % in all homozygous mutation types). Two novel mutations were found in this study: N206K (p.Asn206Lys) and S208T (p.Ser208Tyr). Our findings in this study on the FMF sequence analysis are different from the results obtained from the other regions of Turkey.

Entities:  

Keywords:  FMF; Kahramanmaras; Mutations; Turkey

Mesh:

Substances:

Year:  2015        PMID: 26215181     DOI: 10.1007/s00296-015-3329-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  Frequency of MEFV gene mutations in Hatay province, Mediterranean region of Turkey and report of a novel missense mutation (I247V).

Authors:  Ramazan Gunesacar; Muhammet Murat Celik; Vefik Arica; Sibel Elmacioglu; Oktay Hasan Ozturk
Journal:  Gene       Date:  2014-06-11       Impact factor: 3.688

2.  MEFV mutations in Turkish patients suffering from Familial Mediterranean Fever.

Authors:  N Akar; M Misiroglu; F Yalcinkaya; E Akar; N Cakar; N Tümer; M Akcakus; H Tastan; Y Matzner
Journal:  Hum Mutat       Date:  2000-01       Impact factor: 4.878

Review 3.  Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene.

Authors:  M Pras
Journal:  Scand J Rheumatol       Date:  1998       Impact factor: 3.641

4.  Evaluating MEFV mutation frequency in Turkish familial Mediterranean fever suspected patients and gender correlation: a retrospective study.

Authors:  H Okan Doğan; Yüksel Koca; Gönül Erden; Yaşar Karaaslan; Handan Bozat
Journal:  Mol Biol Rep       Date:  2011-12-30       Impact factor: 2.316

Review 5.  The spectrum of Familial Mediterranean Fever (FMF) mutations.

Authors:  I Touitou
Journal:  Eur J Hum Genet       Date:  2001-07       Impact factor: 4.246

6.  Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population.

Authors:  E Yilmaz; S Ozen; B Balci; A Duzova; R Topaloglu; N Besbas; U Saatci; A Bakkaloglu; M Ozguc
Journal:  Eur J Hum Genet       Date:  2001-07       Impact factor: 4.246

7.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

8.  MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience [corrected].

Authors:  Serbulent Yigit; Hasan Bagci; Ozan Ozkaya; Kazim Ozdamar; Kuddusi Cengiz; Tekin Akpolat
Journal:  J Rheumatol       Date:  2007-12-01       Impact factor: 4.666

Review 9.  Familial Mediterranean fever--a review.

Authors:  Mordechai Shohat; Gabrielle J Halpern
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

10.  Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations.

Authors:  Dai Kishida; Akinori Nakamura; Masahide Yazaki; Ayako Tsuchiya-Suzuki; Masayuki Matsuda; Shu-ichi Ikeda
Journal:  Arthritis Res Ther       Date:  2014-09-27       Impact factor: 5.156

View more
  5 in total

1.  A comprehensive molecular analysis and genotype-phenotype correlation in patients with familial mediterranean fever.

Authors:  Burhan Balta; Murat Erdogan; Aslıhan Kiraz; Tayfun Akalın; Funda Baştug; Arslan Bayram
Journal:  Mol Biol Rep       Date:  2020-01-27       Impact factor: 2.316

2.  The Spectrum of MEFV Gene Mutations and Genotypes in the Middle Northern Region of Turkey.

Authors:  Gokce Celep; Zeynep Hulya Durmaz; Yalciner Erdogan; Seviye Akpinar; Saban Abdullah Kaya; Rıdvan Guckan
Journal:  Eurasian J Med       Date:  2019-10

3.  The Frequency of MEFV Gene Mutations and Genotypes in Sanliurfa Province, South-Eastern Region of Turkey, after the Syrian Civil War by Using Next Generation Sequencing and Report of a Novel Exon 4 Mutation (I423T).

Authors:  Evren Gumus
Journal:  J Clin Med       Date:  2018-05-07       Impact factor: 4.241

4.  Presentation of a new mutation in FMF and evaluating the frequency of distribution of the MEFV gene mutation in our region with clinical findings.

Authors:  Abdullah Arpacı; Serdar Doğan; Hazal Fatma Erdoğan; Çiğdem El; Sibel Elmacıoğlu Cura
Journal:  Mol Biol Rep       Date:  2021-03-18       Impact factor: 2.316

5.  Sequence analysis in Familial Mediterranean Fever patients with no confirmatory genotype.

Authors:  Vasiliki Sgouropoulou; Evangelia Farmaki; Theophanis Papadopoulos; Vasiliki Tzimouli; Jenny Pratsidou-Gertsi; Maria Trachana
Journal:  Rheumatol Int       Date:  2021-06-13       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.